Salarius Pharma receives Nasdaq delisting notice for bid price non-compliance; merger with Decoy planned

Decoy Therapeutics Inc.

Nasdaq notice on April 23, 2025 for failing minimum $1.00 bid price for 30 consecutive business days.
Ineligible for compliance period due to prior reverse stock split; also non-compliant with $2.5M equity standard.
Unless appeal by April 30, 2025, suspension and delisting scheduled for May 2, 2025; company intends to appeal.
Plans to present merger with Decoy Therapeutics Inc. to regain compliance at Nasdaq Hearings Panel.

item 3.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001615219-25-000045
form_type: 8-K
ticker: DCOY
cik: 0001615219
company_name: Decoy Therapeutics Inc.
filed_at: 2025-04-25T23:59:59+00:00
discovered_at: 2026-05-14T18:02:49.029100+00:00
generated_at: 2026-05-23T05:52:19.149307+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.9
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001615219-25-000045
json_url: https://secwatch.observer/filing/0001615219-25-000045.json
markdown_url: https://secwatch.observer/filing/0001615219-25-000045.md
text_url: https://secwatch.observer/filing/0001615219-25-000045.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000045/0001615219-25-000045-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000045/flks-20250423.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001615219-25-000045

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.